Buying the 2018 dip led to massive gains in 2019-2021. Tech (QQQ) Volatile, but stayed flat/positive. Winner. The dominant theme of the last decade. Dividends (VYM) Struggled due to rising rates. Moderate. Better for income than raw growth. The "Best" Pick in Hindsight
Are you looking to compare these against current 2026 market leaders , or are you researching for a specific long-term portfolio analysis?
While still a giant, many investors now prefer the XBI (SPDR S&P Biotech) for its equal-weight approach to smaller, high-growth companies. 3. Short-Term Treasury & Cash (The Safety Net) best etf to buy 2018
Healthcare often acts as a "defensive" sector during volatility. In 2018, breakthroughs in gene therapy boosted specific biotech ETFs. iShares Nasdaq Biotechnology ETF (IBB)
This remains a foundational tech ETF, though it now faces stiff competition from more specialized AI-focused funds. 2. Healthcare & Biotech (The Defensive Play) Buying the 2018 dip led to massive gains in 2019-2021
As of , we can evaluate these 2018 picks with the benefit of hindsight to see which ones stood the test of time. Top ETF Categories of 2018
If you had bought the in 2018, you would have captured the beginning of the massive run-up in Big Tech (Apple, Microsoft, Amazon) that defined the early 2020s. The dominant theme of the last decade
Technology was the standout sector. Funds focusing on cloud computing and software-as-a-service (SaaS) led the pack. First Trust Cloud Computing ETF (SKYY)